Companies
- Companies
- Browse
Companies
BioVex : Developing a new class of vaccines to treat and prevent cancer - OncoVEX and ImmunoVEX, and a functional genomics platform for gene determination in the nervous system - NeuroVEX More
Related Reports
Market Research Reports provided by reports.iptechex.com
Dec 2010 - 19 pages - $99
Jul 2011 - 92 pages - $2,000
Nov 2010 - 324 pages - $1,495
Jul 2011 - 133 pages - $500
Aug 2011 - 8 pages - $75
Aug 2011 - 7 pages - $75
Feb 2011 - 128 pages - $500
Nov 2010 - 26 pages - $125
Nov 2009 - $15,200
Oct 2010 - 71 pages - $2,000
Your selection
Browse By
- Industry sector
- Antibodies
- Antigens
- Biomarkers
- Cell lines
- Mouse models
- Reagents
- Vectors
- Geographic location
- Africa
- Asia
- Australia/New Zealand
- Central America
- Europe
- Near & Far East
- North America
- South America
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us